D. Kerjaschki, Pathogenetic concepts of membranous glomerulopathy (MGN), J Nephrol, vol.13, pp.96-100, 2000.

R. J. Glassock, The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey, Am J Kidney Dis, vol.56, pp.157-167, 2010.

P. Ronco and H. Debiec, Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy, J Am Soc Nephrol, vol.21, pp.564-569, 2010.

P. Simon, M. P. Ramée, V. Autuly, E. Laruelle, C. Charasse et al., Epidemiology of primary glomerular diseases in a French region. Variations according to period and age, Kidney Int, vol.46, pp.1192-1198, 1994.

P. Maisonneuve, L. Agodoa, R. Gellert, J. H. Stewart, G. Buccianti et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study, Am J Kidney Dis, vol.35, pp.157-165, 2000.

A. A. Eddy and J. M. Symons, Nephrotic syndrome in childhood, Lancet, vol.362, pp.629-639, 2003.

A. Chen, R. Frank, S. Vento, V. Crosby, M. Chandra et al., Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome, BMC Nephrol, vol.6, pp.8-11, 2007.

N. Polanco, E. Gutiérrez, A. Covarsí, F. Ariza, A. Carreño et al., Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.21, pp.697-704, 2010.

N. Polanco, E. Gutiérrez, F. Rivera, I. Castellanos, J. Baltar et al., Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment, Nephrol Dial Transplant, vol.27, pp.231-234, 2012.

R. J. Glassock, Diagnosis and natural course of membranous nephropathy, Semin Nephrol, vol.23, pp.324-332, 2003.

R. J. Glassock, The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?, Am J Kidney Dis, vol.44, pp.562-566, 2004.

J. M. Hofstra, F. C. Fervenza, and J. F. Wetzels, Treatment of idiopathic membranous nephropathy, Nat Rev Nephrol, vol.9, pp.443-458, 2013.

M. Waldman, H. A. Austin, and . Iii, Controversies in the treatment of idiopathic membranous nephropathy, Nat Rev Nephrol, vol.5, pp.469-479, 2009.

W. Heymann, D. B. Hackel, S. Harwood, S. Wilson, and J. L. Hunter, Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspension, Proc Soc Exp Biol Med, vol.100, pp.660-664, 1959.

B. J. Van-damme, G. J. Fleuren, W. W. Bakker, R. L. Vernier, and P. J. Hoedemaeker, Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis, Lab Investig, vol.38, pp.502-510, 1978.

W. G. Couser, D. R. Steinmuller, M. M. Stilmant, D. J. Salant, and L. M. Lowenstein, Experimental glomerulonephritis in the isolated perfused rat kidney, J Clin Invest, vol.62, pp.1275-1287, 1978.

D. Kerjaschki and M. G. Farquhar, The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border, Proc Natl Acad Sci, vol.79, pp.5557-5561, 1982.

D. Kerjaschki and M. G. Farquhar, Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats, J Exp Med, vol.157, pp.667-686, 1983.

P. Shah, A. Tramontano, and S. P. Makker, Intramolecular spreading in Heymann nephritis, J Am Soc Nephrol, vol.18, pp.3060-3066, 2007.

C. D. Blosser, R. Ayalon, R. Nair, C. Thomas, and L. H. Beck, Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation, Am J Transplant, vol.12, pp.1637-1642, 2012.

H. Debiec, L. Martin, C. Jouanneau, G. Dautin, L. Mesnard et al., Autoantibodies specific for the phospholipase A(2) receptor in recurrent and de novo membranous nephropathy, Am J Transplant, vol.11, pp.2144-2152, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00919176

H. Debiec, M. Hanoy, A. Francois, D. Guerrot, S. Ferlicot et al., Recurrent membranous nephropathy in an allograft caused by IgG3? targeting the PLA2 receptor, J Am Soc Nephrol, vol.23, pp.1949-1954, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00919065

L. East and C. M. Isacke, The mannose receptor family, Biochim Biophys Acta, vol.1572, pp.364-386, 2002.

O. Llorca, Extended and bent conformations of the mannose receptor family, Cell Mol Life Sci, vol.65, pp.1302-1310, 2008.

A. Behnert, M. J. Fritzler, B. Teng, M. Zhang, F. Bollig et al., An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor, PLoS One, vol.8, issue.4, p.61669, 2013.

A. Vangelista, R. Tazzari, and V. Bonomini, Idiopathic membranous nephropathy in twin brothers, Nephron, vol.50, pp.79-80, 1988.

D. Bockenhauer, H. Debiec, N. Sebire, M. Barratt, P. Warwicker et al., Familial membranous nephropathy: an X-linked genetic susceptibility?, Nephron Clin Pract, vol.108, pp.10-15, 2008.

C. D. Short, J. Feehally, R. Gokal, and N. P. Mallick, Familial membranous nephropathy, Br Med J (Clin Res Ed, vol.289, p.1500, 1984.

D. Vasmant, K. Murnaghan, A. Bensman, J. Y. Muller, and B. Mougenot, Familial idiopathic membranous glomerulonephritis, Int J Pediatr Nephrol, vol.5, pp.193-196, 1984.

K. Sato, H. Oguchi, K. Hora, T. Furukawa, S. Furuta et al., Idiopathic membranous nephropathy in two brothers, Nephron, vol.46, pp.174-178, 1987.

I. Elshihabi, C. I. Kaye, and A. Brzowski, Membranous nephropathy in two human leukocyte antigen-identical brothers, J Pediatr, vol.123, pp.940-942, 1993.

J. S. Chen, A. Chen, L. C. Chang, W. S. Chang, H. S. Lee et al., Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences, Nephrol Dial Transplant, vol.19, pp.2721-2728, 2004.

W. M. Bagchus, P. J. Hoedemaeker, J. T. Vos, and W. W. Bakker, Thymocytes reacting with heterologous antibodies against GP 330 in autologous immune complex glomerulopathy (AICG) in the rat. The relation between susceptibility for AICG and anti-GP 330-binding thymocytes, Immunobiology, vol.179, pp.432-444, 1989.

P. T. Klouda, J. Manos, E. J. Acheson, P. A. Dyer, F. S. Goldby et al., Strong association between idiopathic membranous nephropathy and HLA-DRW3, Lancet, vol.2, pp.770-771, 1979.

L. Petit, J. C. Laurent, B. Berthoux, and F. C. , HLA-DR3 and idiopathic membranous nephritis (IMN) association, Tissue Antigens, vol.20, pp.227-228, 1982.

F. C. Berthoux, E. Alamartine, B. Laurent, P. Berthoux, C. Vacherot et al., Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations, Clin Nephrol, vol.22, pp.15-20, 1984.

R. W. Vaughan, A. G. Demaine, and K. I. Welsh, A DQA1 allele is strongly associated with idiopathic membranous nephropathy, Tissue Antigens, vol.34, pp.261-269, 1989.

P. A. Dyer, C. D. Short, E. A. Clarke, and N. P. Mallick, HLA antigen and gene polymorphisms and haplotypes established by family studies in membranous nephropathy, Nephrol Dial Transplant, vol.7, issue.1, pp.42-47, 1992.

S. H. Sacks, C. Warner, R. D. Campbell, and I. Dunham, Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy, Kidney Int Suppl, vol.39, pp.13-19, 1993.

D. Chevrier, M. Giral, R. Perrichot, D. Latinne, P. Coville et al., Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci, Tissue Antigens, vol.50, pp.164-169, 1997.

H. C. Stanescu, M. Arcos-burgos, A. Medlar, D. Bockenhauer, A. Kottgen et al., Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, pp.616-626, 2011.

D. Kanigicherla, J. Gummadova, E. A. Mckenzie, S. A. Roberts, S. Harris et al., Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy, Kidney Int, vol.83, pp.940-948, 2013.

G. Bullich, J. Ballarín, A. Oliver, N. Ayasreh, I. Silva et al., HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.9, pp.335-343, 2014.

Y. H. Liu, C. H. Chen, S. Y. Chen, Y. J. Lin, W. L. Liao et al., Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan, J Biomed Sci, vol.17, pp.81-88, 2010.

S. Kim, H. J. Chin, K. Y. Na, S. Kim, J. Oh et al., Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy, Nephron Clin Pract, vol.117, pp.253-258, 2011.

J. Lv, W. Hou, X. Zhou, G. Liu, F. Zhou et al., Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy, J Am Soc Nephrol, vol.24, pp.1323-1329, 2013.

M. J. Coenen, J. M. Hofstra, H. Debiec, H. C. Stanescu, A. J. Medlar et al., Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.24, pp.677-683, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919052

C. Bantis, P. J. Heering, S. Aker, M. Siekierka, N. Kuhr et al., Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis, Am Nephrol, vol.26, pp.12-15, 2006.

D. Thibaudin, L. Thibaudin, P. Berthoux, C. Mariat, J. P. Filippis et al., TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy, Kidney Int, vol.71, pp.431-437, 2007.

E. Honkanen, E. Von-willebrand, A. M. Teppo, T. Törnroth, and C. Grönhagen-riska, Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis, Kidney Int, vol.53, pp.909-917, 1998.

T. J. Neale, B. M. Rüger, H. Macaulay, P. R. Dunbar, Q. Hasan et al., Tumor necrosis factoralpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy, Am J Pathol, vol.146, pp.1444-1454, 1995.

S. Tabibzadeh, Q. F. Kong, and S. Kapur, TNF-alpha induces dyscohesion of epithelial cells-association with disassembly of actin filaments, Endocrine, vol.3, pp.549-556, 1995.

T. B. Huber and T. Benzing, The slit diaphragm: a signaling platform to regulate podocyte function, Curr Opin Nephrol Hypertens, vol.14, pp.211-216, 2005.

W. Y. Lo, S. Y. Chen, H. J. Wang, H. C. Shih, C. H. Chen et al., Association between genetic polymorphisms of the NPHS1 gene and membranous in the Taiwanese population, Clin Chim Acta, vol.411, pp.714-718, 2010.

C. H. Chen, K. H. Shu, M. C. Wen, K. J. Chen, C. H. Cheng et al., Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy, Nephrol Dial Transplant, vol.23, pp.3166-3173, 2008.

Y. Luo, C. Wang, and H. Tu, Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome, Mol Med Rep, vol.9, pp.894-898, 2014.

S. Y. Chen, C. H. Chen, Y. C. Huang, H. M. Chuang, M. M. Lo et al., Effect of IL-6C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population, Ren Fail, vol.32, pp.1172-1176, 2010.

S. Y. Chen, C. H. Chen, Y. C. Huang, C. J. Chan, Y. Y. Hsieh et al., Association of STAT4 polymorphisms with susceptibility to primary membranous glomerulonephritis and renal failure, Clin Chim Acta, vol.412, pp.1899-1904, 2011.

Y. T. Chen, C. C. Wei, K. L. Ng, C. H. Chen, C. J. Chan et al., Toll-like receptor 9 SNPs are susceptible to the development and progression of membranous glomerulonephritis: 27 years follow-up in Taiwan, Ren Fail, vol.35, pp.1370-1375, 2013.

H. Debiec and P. Ronco, Nephrotic syndrome: a new specific test for idiopathic membranous nephropathy, Nat Rev Nephrol, vol.7, pp.496-498, 2011.

E. Hoxha, S. Harendza, G. Zahner, U. Panzer, O. Steinmetz et al., An immunofluorescence test for phospholipase-A 2 -receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrol Dial Transplant, vol.26, pp.2526-2532, 2011.

C. Dähnrich, L. Komorowski, C. Probst, B. Seitz-polski, V. Esnault et al., Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy, Clin Chim Acta, vol.421, pp.213-218, 2013.

W. Qin, L. H. Beck, C. Zeng, Z. Chen, S. Li et al., Anti-phospholipase A2 receptor antibody in membranous nephropathy, J Am Soc Nephrol, vol.22, pp.1137-1143, 2011.

M. Knehtl, H. Debiec, P. Kamgang, P. Callard, J. Cadranel et al., A case of phospholipase A 2 receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis, Am J Kidney Dis, vol.57, pp.140-143, 2011.

F. A. Nawaz, C. P. Larsen, and M. L. Troxell, Membranous nephropathy and nonsteroidal anti-inflammatory agents, Am J Kidney Dis, vol.62, pp.1012-1017, 2013.

X. Huang, W. Qin, M. Zhang, C. Zheng, C. Zeng et al., Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy, Am J Med Sci, vol.346, pp.32-37, 2013.

B. Svobodova, E. Honsova, P. Ronco, V. Tesar, and H. Debiec, Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, pp.1839-1844, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919114

C. P. Larsen, N. C. Messias, F. G. Silva, E. Messias, and P. D. Walker, Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies, Mod Pathol, vol.26, pp.709-715, 2013.

H. Debiec and P. Ronco, PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy, N Engl J Med, vol.364, pp.689-690, 2011.

E. Hoxha, U. Kneißler, G. Stege, G. Zahner, I. Thiele et al., Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy, Kidney Int, vol.82, pp.797-804, 2012.

A. Kuroki, T. Shibata, H. Honda, D. Totsuka, K. Kobayashi et al., Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy, Intern Med, vol.41, pp.936-942, 2002.

H. Ohtani, H. Wakui, A. Komatsuda, S. Okuyama, R. Masai et al., Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy, Nephrol Dial Transplant, vol.19, pp.574-579, 2004.

Y. Segawa, S. Hisano, M. Matsushita, T. Fujita, S. Hirose et al., IgG subclasses and complement pathway in segmental and global membranous nephropathy, Pediatr Nephrol, vol.25, pp.1091-1099, 2010.

Z. Qu, G. Liu, J. Li, L. H. Wu, Y. Tan et al., Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy, Nephrol Dial Transplant, vol.27, pp.1931-1937, 2012.

J. M. Hofstra, L. H. Beck, D. M. Beck, J. F. Wetzels, and D. J. Salant, Anti-phospholipase A 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.6, pp.1286-1291, 2011.

L. H. Beck, F. C. Fervenza, D. M. Beck, R. G. Bonegio, F. A. Malik et al., Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy, J Am Soc Nephrol, vol.22, pp.1543-1550, 2011.

J. M. Hofstra, H. Debiec, C. D. Short, T. Pellé, R. Kleta et al., Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.23, pp.1735-1743, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00919117

Y. J. Oh, S. H. Yang, D. K. Kim, S. W. Kang, and Y. S. Kim, Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy, PLoS One, vol.8, p.62151, 2013.

J. Hofstra, A. Bech, P. Brenchley, and J. Wetzels, Measurement of anti PLA2R antibodies predicts relapse rate after immunosuppressive therapy in patients with idiopathic membranous nephropathy, 2013.

S. L. Hu, D. Wang, W. J. Gou, Q. F. Lei, T. A. Ma et al., Diagnostic value of phospholipase A(2) receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis, J Nephrol, vol.27, pp.111-116, 2014.

E. M. Briganti, G. R. Russ, J. J. Mcneil, R. C. Atkins, and S. J. Chadban, Risk of renal allograft loss from recurrent glomerulonephritis, N Engl J Med, vol.347, pp.103-109, 2002.

T. S. Dabade, J. P. Grande, S. M. Norby, F. C. Fervenza, and F. G. Cosio, Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study, Am J Transplant, vol.8, pp.1318-1322, 2008.

C. P. Larsen and P. D. Walker, Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy, Transplantation, vol.95, pp.1259-1262, 2013.

S. Takahashi, K. Hiromura, M. Tsukida, Y. Ohishi, H. Hamatani et al., Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency, J Am Soc Nephrol, vol.24, pp.1305-1312, 2013.

M. Prunotto, M. L. Carnevali, G. Candiano, C. Murtas, M. Bruschi et al., Autoimmunity in membranous nephropathy targets aldose reductase and SOD2, J Am Soc Nephrol, vol.21, pp.507-519, 2010.

M. Bruschi, M. L. Carnevali, C. Murtas, G. Candiano, A. Petretto et al., Direct characterization of target podocyte antigens and autoantibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens, J Proteomics, vol.74, pp.2008-2017, 2011.

C. Murtas, M. Bruschi, G. Candiano, G. Moroni, R. Magistroni et al., Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy, Clin J Am Soc Nephrol, vol.7, pp.1394-1400, 2012.

P. Ronco, H. Debiec, and H. Imai, Circulating antipodocyte antibodies in membranous nephropathy: pathophysiologic and clinical relevance, Am J Kidney Dis, vol.62, pp.16-19, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919046

H. Debiec, F. Lefeu, M. J. Kemper, P. Niaudet, G. Deschênes et al., Early childhood membranous nephropathy due to cationic bovine serum albumin, N Engl J Med, vol.364, pp.2101-2110, 2011.

S. K. Sathe, S. S. Teuber, and K. H. Roux, Effects of food processing on the stability of food allergens, Biotechnol Adv, vol.23, pp.423-429, 2005.

C. Sanchez and S. Fremont, Consequences of heat treatment and processing of food on the structure and allergenicity of component proteins, Rev Fr Allergol Immunol Clin, vol.43, pp.13-20, 2003.

R. M. Van-elburg, W. P. Fetter, C. M. Bunkers, and H. S. Heymans, Intestinal permeability in relation to birth weight and gestational and postnatal age, Arch Dis Child Fetal Neonatal Ed, vol.88, pp.52-55, 2003.

R. Sreedharan and D. I. Mehta, Gastrointestinal tract. Pediatrics, vol.113, pp.1044-1050, 2004.

F. Torente and S. Murch, Food allergic enteropathy, Pediatric gastrointestinal disease, pp.944-958, 2004.

S. M. Richards, Immunologic considerations for enzyme replacement therapy in the treatment of lysosomal storage disorders, Clin Appl Immunol Rev, vol.2, pp.241-253, 2002.

D. A. Brooks, Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models, Mol Genet Metab, vol.68, pp.268-275, 1999.

E. Koren, L. A. Zuckerman, and A. R. Mire-sluis, Immune responses to therapeutic proteins in humans-clinical significance, assessment and prediction, Curr Pharm Biotechnol, vol.3, pp.349-360, 2002.

T. E. Hunley, D. Corzo, M. Dudek, P. Kishnani, A. Amalfitano et al., Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease, Pediatrics, vol.114, pp.532-535, 2004.

H. Debiec, V. Valayannopoulos, O. Boyer, L. H. Nöel, P. Callard et al., Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy, J Am Soc Nephrol, vol.25, pp.675-680, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919024

S. C. Jordan, B. Buckingham, R. Sakai, and D. Olson, Studies of immune-complex glomerulonephritis mediated by human thyroglobulin, N Engl J Med, vol.304, pp.1212-1215, 1981.

W. H. Hörl and D. Kerjaschki, Membranous glomerulonephritis (MGN), J Nephrol, vol.13, pp.291-316, 2000.

R. Bhimma and H. M. Coovadia, Hepatitis B virus-associated nephropathy, Am J Nephrol, vol.24, pp.198-211, 2004.

K. Nakahara, H. Takahashi, C. Okuse, R. Shigefuku, N. Yamada et al., Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection, Intern Med, vol.49, pp.383-388, 2010.

E. Guiard, A. Karras, E. Plaisier, D. Van-huyen, J. P. Fakhouri et al., Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab, Clin J Am Soc Nephrol, vol.6, pp.1609-1616, 2011.

S. De-seigneux, P. Bindi, H. Debiec, M. A. Alyanakian, B. Aymard et al., Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties, Am J Kidney Dis, vol.56, pp.117-121, 2010.

K. Lundberg and P. J. Venables, Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis, Arthritis Res Ther, vol.10, p.122, 2008.

L. Chen, T. Hellmark, V. Pedchenko, B. G. Hudson, C. D. Pusey et al., A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis, J Am Soc Nephrol, vol.17, pp.3076-3081, 2006.

S. Adler and X. Chen, Anti-Fx1A antibody recognizes a beta 1-integrin on glomerular epithelial cells and inhibits adhesion and growth, Am J Physiol, vol.262, pp.770-776, 1992.

B. A. Binstadt, P. R. Patel, H. Alencar, P. A. Nigrovic, D. M. Lee et al., Particularities of the vasculature can promote the organ specificity of autoimmune attack, Nat Immunol, vol.7, pp.284-292, 2006.

S. T. Spicer, G. T. Tran, M. C. Killingsworth, N. Carter, D. A. Power et al., Induction of passive Heymann nephritis in complement component 6-deficient PVG rats, J Immunol, vol.179, pp.172-178, 2007.

P. L. Leenaerts, B. M. Hall, B. J. Van-damme, M. R. Daha, and Y. F. Vanrenterghem, Active Heymann nephritis in complement component C6 deficient rats, Kidney Int, vol.47, pp.1604-1614, 1995.

D. Kerjaschki, M. Exner, R. Ullrich, M. Susani, L. K. Curtiss et al., Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis, J Clin Invest, vol.100, pp.2303-2309, 1997.

A. J. Turner, R. E. Isaac, and D. Coates, The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function, Bioessays, vol.23, pp.261-269, 2001.

P. Ancian, G. Lambeau, and M. Lazdunski, Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2, Biochemistry, vol.34, pp.13146-13151, 1995.

E. Zvaritch, G. Lambeau, and M. Lazdunski, Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2, J Biol Chem, vol.271, pp.250-257, 1996.

K. Hanasaki and H. Arita, Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2, Prostaglandins Other Lipid Mediat, vol.69, pp.71-82, 2002.

G. Lambeau and M. H. Gelb, Biochemistry and physiology of mammalian secreted phospholipases A2, Annu Rev Biochem, vol.77, pp.495-520, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00315356

A. Augert, C. Payré, Y. De-launoit, J. Gil, G. Lambeau et al., The M-type receptor PLA2R regulates senescence through the p53 pathway, EMBO Rep, vol.10, pp.271-217, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417702

B. Sis, A. Tasanarong, F. Khoshjou, F. Dadras, K. Solez et al., Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease, Kidney Int, vol.71, pp.218-226, 2007.

A. V. Cybulsky, R. J. Quigg, and D. J. Salant, Experimental membranous nephropathy redux, Am J Physiol Renal Physiol, vol.289, pp.660-671, 2005.

J. V. Sarma and P. A. Ward, The complement system, Cell Tissue Res, vol.343, pp.227-235, 2011.

B. P. Morgan and C. L. Haris, Regulation in the activation pathways, Complement regulatory proteins. Academic, pp.41-136, 1999.

A. Naik, S. Sharma, and R. J. Quigg, Complement regulation in renal disease models, Semin Nephrol, vol.33, pp.575-585, 2013.

C. Loirat and V. Frémeaux-bacchi, Atypical hemolytic uremic syndrome, Orphanet J Rare Dis, vol.6, pp.60-90, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02157634

A. E. Hughes, N. Orr, H. Esfandiary, M. Diaz-torres, T. Goodship et al., A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration, Nat Genet, vol.38, pp.1173-1177, 2006.

B. Gold, J. E. Merriam, J. Zernant, L. S. Hancox, A. J. Taiber et al., Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration, AMD Genetics Clinical Study Group, vol.38, pp.458-462, 2006.

J. S. Van-der-zee, P. Van-swieten, and R. C. Aalberse, Inhibition of complement activation by IgG4 antibodies, Clin Exp Immunol, vol.64, pp.415-422, 1986.

R. C. Aalberse and J. Schuurman, IgG4 breaking the rules, Immunology, vol.105, pp.9-19, 2002.

C. C. Huang, A. Lehman, A. Albawardi, A. Satoskar, S. Brodsky et al., IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression, Mod Pathol, vol.26, pp.799-805, 2013.

K. Lhotta, R. Würzner, and P. König, Glomerular deposition of mannose-binding lectin in human glomerulonephritis, Nephrol Dial Transplant, vol.14, pp.881-886, 1999.

M. Espinosa-hernández, R. Ortega-salas, M. López-andreu, J. M. Gómez-carrasco, M. J. Pérez-sáez et al., C4d as a diagnostic tool in membranous nephropathy, Nefrologia, vol.32, pp.295-299, 2012.

S. Thiel and M. Gadjeva, Humoral pattern recognition molecules: mannan-binding lectin and ficolins, Adv Exp Med Biol, vol.653, pp.58-73, 2009.

R. Malhotra, M. R. Wormald, P. M. Rudd, P. B. Fischer, R. A. Dwek et al., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein, Nat Med, vol.1, pp.237-243, 1995.

A. Bond, A. Alavi, J. S. Axford, B. E. Bourke, F. E. Bruckner et al., A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine, J Autoimmun, vol.10, pp.77-85, 1997.

R. Parekh, D. Isenberg, G. Rook, I. Roitt, R. Dwek et al., A comparative analysis of disease-associated changes in the galactosylation of serum IgG, J Autoimmun, vol.2, pp.101-114, 1989.

H. Ma, L. H. Beck, and D. Salant, 62A, abstr. ASN congress in, vol.22, 2011.

T. Rispens, P. Ooievaar-de-heer, E. Vermeulen, J. Schuurman, M. Van-der-neut-kolfschoten et al., Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions, J Immunol, vol.182, pp.4275-4281, 2009.

T. Ito, K. Kitahara, T. Umemura, M. Ota, Y. Shimozuru et al., A novel heterophilic antibody interaction involves IgG4, Scand J Immunol, vol.71, pp.109-114, 2010.

M. Nangaku, S. J. Shankland, and W. G. Couser, Cellular response to injury in membranous nephropathy, J Am Soc Nephrol, vol.16, pp.1195-1204, 2005.

P. N. Cunningham and R. J. Quigg, Contrasting roles of complement activation and its regulation in membranous nephropathy, J Am Soc Nephrol, vol.16, pp.1214-1222, 2005.

C. A. Tegla, C. Cudrici, S. Patel, . Trippe-r-3rd, V. Rus et al., Membrane attack by complement: the assembly and biology of terminal complement complexes, Immunol Res, vol.51, pp.45-60, 2011.

O. Bohana-kashtan, L. Ziporen, N. Donin, S. Kraus, and Z. Fishelson, Cell signals transduced by complement. Mol Immunol, vol.41, pp.583-597, 2004.

O. Moskovich and Z. Fishelson, Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex, J Biol Chem, vol.28, pp.29977-29986, 2000.

D. Kerjaschki, M. Schulze, S. Binder, R. Kain, P. P. Ojha et al., Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy, J Immunol, vol.143, pp.546-552, 1989.

S. P. Kon, B. Coupes, C. D. Short, L. R. Solomon, M. J. Raftery et al., Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy, Kidney Int, vol.48, pp.1953-1958, 1995.

A. V. Cybulsky, Endoplasmic reticulum stress in proteinuric kidney disease, Kidney Int, vol.7, pp.187-193, 2010.

A. V. Cybulsky, The intersecting roles of endoplasmic reticulum stress, ubiquitin-proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease, Kidney Int, vol.84, pp.25-33, 2013.

L. Wang, Q. Hong, Y. Lv, Z. Feng, X. Zhang et al., Autophagy can repair endoplasmic reticulum stress damage of the passive Heymann nephritis model as revealed by proteomics analysis, J Proteomics, vol.75, pp.3866-3876, 2012.

C. Meyer-schwesinger, T. N. Meyer, H. Sievert, E. Hoxha, M. Sachs et al., Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy, Am J Pathol, vol.178, pp.2044-2057, 2011.

C. Meyer-schwesinger, T. N. Meyer, S. Münster, P. Klug, M. Saleem et al., A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies, J Pathol, vol.217, pp.452-464, 2009.

C. Hetz, The unfolded protein response: controlling cell fate decisions under ER stress and beyond, Nat Rev Mol Cell Biol, vol.13, pp.89-102, 2012.